My research program and clinical practice are focused on improving the detection, prevention and treatment of heart failure, especially as it relates to cancer therapy. Much of my work involves multidisciplinary collaboration with biomedical engineering, nursing, oncology, exercise physiology and basic science. This amazing environment stimulates the exchange of novel ideas and helps foster innovation.
Dr. Paterson received his medical degree from McGill University in 1995, trained there in internal medicine and cardiology, and completed a fellowship in cardiac MRI at the National Institutes of Health in Bethesda, Maryland. He was recruited to the Department of Medicine in 2004 and became professor in 2017.
Leadership and Collaborations:
Dr. Paterson is the academic/research director for cardiac magnetic resonance imaging and founder and director of the Edmonton Cardio-Oncology Program at the Mazankowski Alberta Heart Institute at the University of Alberta. He is past president of the Canadian Society for Cardiovascular Magnetic Resonance and continues to serve on the executive board. He has chaired and/or co-authored national guidelines on cardiac MRI as well as cardio-oncology. He is a board member of the Canadian Cardiac Oncology Network and co-leader of the education section. He and his colleagues received the Department of Medicine 2015 award for Cooperation, Collaboration and Teamwork for the establishment of Edmonton Cardio-Oncology program.
Dr. Paterson gives clinical instruction and supervises residents in the adult cardiology training program and advanced cardiac imaging rotation. He also enjoys teaching ECG interpretation and organizes regular teaching rounds with the residents. He is past program director for adult cardiology (2009-2017) and continues to serve on the training committee. He supervises graduate and post-graduate students and mentors several clinical trainees.
Dr. Paterson’s research interests include cardiovascular imaging in heart failure, transplantation and cardio-oncology. He has published dozens of scientific articles, abstracts and book chapters and frequently presents regionally, nationally and internationally on his research. In 2017, his team published a landmark study in the Journal of Clinical Oncology showing that beta blockers protect against heart injury during breast cancer treatment. He won the Most Important Publication in Heart Transplantation for 2015 from the Journal of Heart and Lung Transplantation. He is an associate editor for the Canadian Journal of Cardiology Open and a review editor for Frontiers in Cardiovascular Medicine: Cardio-Oncology.
In addition to his current research funding from provincial and national organizations, Dr. Paterson has received peer-reviewed funding from the University Hospital Foundation, Alberta Innovates-Health Solutions, Alberta Cancer Foundation, the Canadian Breast Cancer Research Alliance, the Heart and Stroke Foundation of Canada and the Canadian Institutes of Health Research.
Cardiac MRI, cardio-oncology, heart failure
Pituskin E, Mackey JR, Koshman S, Jassal D, Pitz M, Haykowsky MJ, Pagano JJ, Chow K, Thompson RB, Oudit GY, Ezekowitz, JA, Paterson DI. Multidisciplinary Approach to Novel Therapies in Cardio-Oncology Research: (MANTICORE 101 – Breast): a Randomized Trial for the Prevention of Trastuzumab Associated Cardiotoxicity. J Clin Oncol. 2017 Mar 10;35(8):870-877.
Dr. Paterson has expertise in the diagnosis and management of patients with cardiomyopathy and heart failure. He has a busy outpatient practice caring for patients with cardiac disease with emphasis on those with or at risk for heart failure. He can also be found interpreting cardiac scans in the Elko MRI centre as well as electrocardiograms for the University of Alberta Hospital.
In 2010, Dr. Paterson co-founded the Edmonton Cardio-Oncology program, which helps more than 250 patients/year complete their cancer therapy.